romiplostim
Showing 26 - 33 of 33
Immune Thrombocytopenia (ITP) Trial in China (Romiplostim)
Completed
- Immune Thrombocytopenia (ITP)
- Romiplostim
-
Beijing, China
- +4 more
Oct 11, 2017
Immune Thrombocytopenia Trial in Beijing (Romiplostim, Placebo)
Completed
- Immune Thrombocytopenia
- Romiplostim
- Placebo
-
Beijing, ChinaPeking Union Medical College Hospital
Aug 15, 2017
Hepatitis C Infection, Thrombocytopenia Trial in Los Angeles (biological, drug, other)
Terminated
- Hepatitis C Infection
- Thrombocytopenia
- romiplostim
- +4 more
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center
Apr 9, 2017
Idiopathic Thrombocytopenic Purpura, Thrombocytopenia, Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic)
Completed
- Idiopathic Thrombocytopenic Purpura
- +5 more
- Romiplostim
- Placebo
-
Orange, California
- +32 more
Feb 7, 2017
Immune Thrombocytopenia Trial (Romiplostim)
Unknown status
- Immune Thrombocytopenia
- Romiplostim
- (no location specified)
Jan 11, 2015
Lung Cancer, Chemo-Induced Thrombocytopenia, NSCLC Trial in Worldwide (Romiplostim, Placebo, Gemcitabine)
Completed
- Lung Cancer
- +7 more
- Romiplostim
- +4 more
-
Glendale, Arizona
- +112 more
Sep 18, 2013